R&D Cloud platform for biotech product development and scientific workflows
Benchling serves biotech R&D teams with a cloud platform built on Python, React, SQL, and AWS infrastructure. The company is investing heavily in scientific AI (Claude integration, AlphaFold), cloud-native tooling (Kubernetes, Istio, EKS), and enterprise integrations (Workato, Salesforce ecosystem) while tackling regulated compliance and legacy system interoperability—pain points that persist across their customer base. Hiring is split evenly between engineering and sales, with 62 roles posted in the last 30 days, indicating aggressive scaling.
Benchling provides an R&D Cloud platform designed for biotech and life-science companies developing drugs, biologics, and materials. The platform addresses core workflows: small-molecule R&D, antibody discovery, registry and inventory management, and cloud-based integrations via a developer API. Customers operate in regulated environments (GxP compliance, software validation) and complex IT ecosystems where legacy systems and spreadsheet-based workflows remain entrenched. The company is 501–1,000 employees, headquartered in San Francisco, and hiring across the United States, Denmark, Germany, Switzerland, and the United Kingdom.
Benchling runs on Python, SQL, Node.js, React, and AWS (EKS, ECS, RDS, VPC). Data and monitoring are handled by Datadog and Sentry. Integrations include Salesforce, Workday, NetSuite, Workato, and Claude for AI.
Active projects include small-molecule R&D solutions, antibody discovery workflows, scientific AI product experiences, registry and inventory systems, cloud-based developer integrations, and performance/scalability improvements for regulated enterprise environments.
Other companies in the same industry, closest in size